Accuronix Therapeutics Overview

  • Founded

  • 2015

Founded
  • Status

  • Private

  • Employees

  • 3

Employees
  • Latest Deal Type

  • Seed

  • Latest Deal Amount

  • $192K

  • Investors

  • 4

Accuronix Therapeutics General Information

Description

Developer of novel therapies designed to solve the most difficult problems in cancer therapy. The company's therapies are based on technology that selectively targets Sigma-2 receptors overexpressed on cancer cells, enabling doctors to increase efficacy and reduce toxicity risk.

Contact Information

Website
www.accuronix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4340 Duncan Avenue
  • Suite 210
  • Saint Louis, MO 63110
  • United States

Accuronix Therapeutics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuronix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 30-Sep-2020 $192K 00000 Completed Generating Revenue
5. Grant 23-Sep-2019 00.000 00000 Completed Generating Revenue
4. Seed Round Cancelled Generating Revenue
3. Grant 01-Sep-2019 00000 00000 Completed Generating Revenue
2. Early Stage VC 28-Jan-2016 $625K $650K Completed Generating Revenue
1. Early Stage VC $25K $25K Completed Startup
To view Accuronix Therapeutics’s complete valuation and funding history, request access »

Accuronix Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapies designed to solve the most difficult problems in cancer therapy. The company's therapies ar
Biotechnology
Saint Louis, MO
3 As of 2021
00000
000000000 00000

000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000 000000000
Schlieren, Switzerland
00 As of 0000
000.00
00000000000 000.00

000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
New Haven, CT
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Accuronix Therapeutics Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunOs Therapeutics Venture Capital-Backed Schlieren, Switzerland 00 000.00 00000000000 000.00
0000000 Formerly VC-backed New Haven, CT 000 00000 000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Venture Capital-Backed San Diego, CA 00 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Bozeman, MT 000.00 0000000000 000.00
You’re viewing 5 of 29 competitors. Get the full list »

Accuronix Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Bradley Keller Ph.D Chief Executive Officer, President, Secretary & Board Member
Robert Mach Ph.D Co-Founder
William Hawkins MD Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

Accuronix Therapeutics Board Members (3)

Name Representing Role Since
Bradley Keller Ph.D Accuronix Therapeutics Chief Executive Officer, President, Secretary & Board Member 000 0000
Charles Bolten BioGenerator Board Member 000 0000
Tim Campbell Accuronix Therapeutics Board Member 000 0000
To view Accuronix Therapeutics’s complete board members history, request access »

Accuronix Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accuronix Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
BioGenerator Venture Capital Minority 000 0000 000000 0
Missouri Technology Corporation Venture Capital Minority 000 0000 000000 0
To view Accuronix Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial